Search research articles
Contact Us
Filters
Showing results (131-140 of 2,087) with videos related to
Page
of 209
Sort By:
RMD Open
|
November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelines
Vanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
RMD Open
|
November 16, 2016
MicroRNAs interfere with DNA methylation in rheumatoid arthritis synovial fibroblasts
Niharika Gaur, Emmanuel Karouzakis, Selene Glück, et al.
RMD Open
|
December 10, 2016
Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective
Meliha C Kapetanovic, Mohaned Hameed, Aleksandra Turkiewicz, et al.
RMD Open
|
January 27, 2017
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
Meghna Jani, William G Dixon, Lianne Kersley-Fleet, et al.
RMD Open
|
March 20, 2019
Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
Paul Bird, Stephen Hall, Peter Nash, et al.
RMD Open
|
August 27, 2025
Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis
Aya Berman, Gili Kenet, Aharon Lubetsky, et al.
RMD Open
|
September 3, 2025
Accrual of thromboembolic events and antiphospholipid syndrome in new-onset systemic lupus erythematosus: a population-based inception cohort study
Sigrid Reppe Moe, Hilde Haukeland, Cathrine Brunborg, et al.
RMD Open
|
May 20, 2020
Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin
Alessia Alunno, Francesco Carubbi, Javier Rodríguez-Carrio
RMD Open
|
May 7, 2020
Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison
B Fautrel, B Zhu, P C Taylor, et al.
RMD Open
|
March 28, 2023
Pilot study of tocilizumab monotherapy for active chronic periaortitis
Anqi Wang, Linyi Peng, Jiaxin Zhou, et al.
Page
of 209
Search research articles
Search
Showing results (131-140 of 2,087) with videos related to
Sort By:
Page
of 209
RMD Open
|
November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelines
Vanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
RMD Open
|
November 16, 2016
MicroRNAs interfere with DNA methylation in rheumatoid arthritis synovial fibroblasts
Niharika Gaur, Emmanuel Karouzakis, Selene Glück, et al.
RMD Open
|
December 10, 2016
Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective
Meliha C Kapetanovic, Mohaned Hameed, Aleksandra Turkiewicz, et al.
RMD Open
|
January 27, 2017
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA
Meghna Jani, William G Dixon, Lianne Kersley-Fleet, et al.
RMD Open
|
March 20, 2019
Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
Paul Bird, Stephen Hall, Peter Nash, et al.
RMD Open
|
August 27, 2025
Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis
Aya Berman, Gili Kenet, Aharon Lubetsky, et al.
RMD Open
|
September 3, 2025
Accrual of thromboembolic events and antiphospholipid syndrome in new-onset systemic lupus erythematosus: a population-based inception cohort study
Sigrid Reppe Moe, Hilde Haukeland, Cathrine Brunborg, et al.
RMD Open
|
May 20, 2020
Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin
Alessia Alunno, Francesco Carubbi, Javier Rodríguez-Carrio
RMD Open
|
May 7, 2020
Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison
B Fautrel, B Zhu, P C Taylor, et al.
RMD Open
|
March 28, 2023
Pilot study of tocilizumab monotherapy for active chronic periaortitis
Anqi Wang, Linyi Peng, Jiaxin Zhou, et al.
Page
of 209